^
    Back
    Association details:
    Biomarker:BST1 positive
    Cancer:Acute Myelogenous Leukemia
    Drug:S63845 (MCL1 inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    New
    Source:
    EACR 2021
    Title:

    CD157/BST-1 mediates pro-survival signals in acute myeloid leukemia

    Published date:
    05/28/2021
    Excerpt:
    ...S63845 significantly increases the therapeutic efficacy of AraC in CD157-positive but not in CD157-negative AML..